Glucoză Plasco B. Braun

Glucoză Plasco B. Braun is a pharmaceutical product that contains glucose monohydrate as its active ingredient. It is supplied in a sterile aqueous form intended for clinical use within the European Union market. The solution provides a readily absorbable source of carbohydrate for patients who require rapid glucose supplementation under medical supervision.

Glucoză Plasco B. Braun is employed in several clinical situations where rapid glucose replacement is needed. It is commonly used for: - Intravenous fluid therapy to correct hypoglycemia. - Providing caloric support during peri‑operative care. - Managing metabolic emergencies such as insulin overdose. - Supplementing nutrition in patients unable to ingest food orally. - Supporting electrolyte balance when combined with appropriate salts.

Side effects of glucose monohydrate solutions are generally related to the route of administration and the osmolarity of the product.

Common: - Local irritation at the infusion site. - Transient hyperglycemia. - Fluid overload in susceptible patients. - Electrolyte shifts, especially potassium.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic reactions such as rash or anaphylaxis. - Pulmonary edema in patients with cardiac dysfunction. - Metabolic acidosis if administered in excess.

When using Glucoză Plasco B. Braun, healthcare professionals should observe several safety measures: - Verify patient blood glucose levels before administration. - Adjust infusion rate in patients with renal or cardiac impairment. - Monitor for signs of fluid overload during prolonged therapy. - Use aseptic technique to prevent contamination. - Avoid rapid bolus administration unless clinically indicated. - Document any adverse reactions promptly.

Glucose solutions can interact with other medications and clinical conditions. Awareness of these interactions helps prevent complications.

Avoid: - Co‑administration with high‑dose insulin without glucose monitoring. - Simultaneous infusion of hypertonic solutions that may exacerbate hyperglycemia.

Use with caution: - Concurrent use of diuretics that affect fluid balance. - Medications that alter potassium levels, such as ACE inhibitors. - Patients receiving total parenteral nutrition (TPN) formulations. - Drugs that may cause hypoglycemia, requiring closer glucose surveillance.